1-6 of 6
imipenem/cilastatin
Close
Save search
Sort by
Journal Articles

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Free
Mojtaba Akhtari, MD, Mindy Hsiao, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4507.
https://doi.org/10.1182/blood.V130.Suppl_1.4507.4507
Published: 2017
Journal Articles

Doripenem Versus Meropenem As the First-Line Empirical Therapy in High-Risk Febrile Neutropenic Patients with Hematological Malignancy: A Randomized, Controlled Trial

Free
Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Yasunori Nakagawa, MD, PhD, Takahiro Mine, MD, Ichiro Hanamura, MD, PhD, Maki Asahi, MD, Yukiteru Fujishima, MD, Yusei Aoki, MD, Shugo Kowata, MD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 4954.
https://doi.org/10.1182/blood.V124.21.4954.4954
Published: 2014
Journal Articles

Treatment with Antibiotics Containing Activity Against Obligate Anaerobes Worsens Gvhd Survival in Mice and Humans after Allogeneic BMT

Free
Yusuke Shono, MD PhD, Melissa D. Docampo, Odette M. Smith, Jyotsna Gupta, Sophia R. Liberman, Ying Taur, MD, Kenya Honda, MD PhD, Marcel R.M. van den Brink, MD PhD, Robert R. Jenq, MD
Journal: Blood
Blood (2014) 124 (21): 186.
https://doi.org/10.1182/blood.V124.21.186.186
Published: 2014
Journal Articles

Doripenem Versus Meropenem For Empirical Antimicrobial Therapy In High Risk Febrile Neutropenic Patients With Hematological Malignancies: A Randomized, Controlled Trial

Free
Yuka Fujisawa, M.D., Tatsuo Oyake, M.D., Ph.D., Takahiro Mine, M.D., Yusei Aoki, M.D., Yasuhiko Tsukushi, M.D., Ph.D., Takeshi Sugawara, M.D., Masato Seguchi, M.D., Ph.D., Ichiro Hanamura, M.D., Ph.D., Yasuaki Nakagawa, M.D., Ph.D., Kazunori Murai, M.D., Ph.D., Shigeki Ito, M.D., Ph.D., Yoji Ishida, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 4716.
https://doi.org/10.1182/blood.V122.21.4716.4716
Published: 2013
Journal Articles

Cefozoplan, Meropenem, or Imipenem-Cilastatin Versus Cefepime As an Empirical Therapy in High Risk Febrile Neutropenic Adult Patients: A Multicenter Prospective Randomized Trial

Free
Takahiko Nakane, MD, PhD, Toshiharu Tamaki, Kazuo Tamura, MD, PhD, Isao Yoshida, MD, Toshihiro Fukushima, MD, PhD, Yoichi Tatsumi, MD, PhD, Yasunori Nakagawa, MD, Kazuo Hatanaka, MD, Tsutomu Takahashi, MD, PhD, Nobu Akiyama, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuma Ohyashiki, MD, PhD, Akio Urabe, MD, PhD, Tohru Masaoka, MD, PhD, Akihisa Kanamaru, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1037.
https://doi.org/10.1182/blood.V120.21.1037.1037
Published: 2012
Journal Articles

Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles

Free
Christian Karl Kjellander, MD, Honar Cherif, MD, PhD, Magnus Björkholm, MD, PhD, Mats Kalin, Md, PhD, Christian G Giske, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4868.
https://doi.org/10.1182/blood.V116.21.4868.4868
Published: 2010